Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Acceleron Receives Two FDA Orphan Designations for ACE-536
Acceleron Receives Two FDA Orphan Designations for ACE-536
Acceleron Receives Two FDA Orphan Designations for ACE-536
Submitted by
admin
on March 26, 2013 - 10:34am
Source:
Yahoo
News Tags:
FDA
orphan drugs
ACE-536
Acceleron
beta-thalassemia
myelodysplastic syndromes
Headline:
Acceleron Receives Two FDA Orphan Designations for ACE-536
Do Not Allow Advertisers to Use My Personal information
